Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Cardiovascular Imaging
What is the preferred imaging modality to evaluate subaortic membranes in patients with aortic valve disease?
Answer from: at Academic Institution
Transesophageal echocardiography is the preferred modality for evaluating subaortic membranes, especially if transthoracic echo is equivocal.
Sign In
or
Register
to read more
20013
Related Questions
Should there be age cut-off considerations when ordering TTEs with bubble routinely as part of stroke work-up?
What is a reasonable imaging modality for older patients with pAfib already on systemic anticoagulation outpatient but presenting with suspected cardioembolic stroke and TTE without evidence of LV thrombus?
What are some TTE findings that suggest worsening function of a bioprosthetic AVR that would require further surveillance or diagnostic imaging?
What is the role of MRI in assessing the risk of embolism in patients with persistent left ventricular thrombus following myocardial infarction?
How long do you recommend waiting after variceal bleeding and banding before a transesophageal echocardiogram can be performed safely?
For asymptomatic, incidentally found Lambl's excrescence, should long-term surveillance imaging be considered and if so, how often should repeat imaging be ordered?
What are the best techniques to reduce POCUS artifact and increase the diagnostic accuracy of lung ultrasound?
Does the presence of diastolic dysfunction guide subsequent pharmacological, pacing and ablative therapies for atrial fibrillation?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
What is a reasonable stepwise approach to diagnostic imaging when there is ongoing concern for cardiac amyloidosis?